Withus Pharmaceutical Co

Withus Pharmaceutical Co Interest Coverage

The Interest Coverage Ratio of Withus Pharmaceutical Co (330350.KQ) as of Nov 11, 2026 is 11.75. In the previous year, Interest Coverage Ratio was 4.80 — a change of 144.78% (higher).

Interest Coverage

11.75

YoY

144.78%

Last updated:

Interest Coverage Ratio of Withus Pharmaceutical Co is 2024 11.75 . Interest Coverage Ratio of Withus Pharmaceutical Co was 2023 4.80 . It decreases by 144.78% higher compared to the previous year.

The Withus Pharmaceutical Co Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2017
142.74 KRW
Jan 1, 2018
32.07 KRW
Jan 1, 2019
17.57 KRW
Jan 1, 2020
2.54 KRW
Jan 1, 2021
4.68 KRW
Jan 1, 2022
16.52 KRW
Jan 1, 2023
4.80 KRW
Jan 1, 2024
11.75 KRW
The Withus Pharmaceutical Co Interest Coverage history
YEARInterest CoverageYoY
11.75+144.78%
4.80-70.94%
16.52+252.90%
4.68+84.46%
2.54-85.56%
17.57-45.20%
32.07-77.53%
142.74—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Withus Pharmaceutical Co Stock analysis

What does Withus Pharmaceutical Co do? Withus Pharmaceutical Co Ltd is a pharmaceutical company based in Seoul, South Korea, operating within the healthcare sector. The company focuses on the manufacturing and distribution of prescription drugs, with its headquarters located in Seoul. As of the latest available information, Withus Pharmaceutical employs 191 full-time staff members. The company completed its initial public offering (IPO) on July 3, 2020, marking its entry into the public market. Its primary product categories include circulatory agents, musculoskeletal agents, digestive agents, antibiotics, and other prescription medications. Additionally, the company engages in contract manufacturing operations (CMO), providing manufacturing services for other pharmaceutical entities. Withus Pharmaceutical maintains a corporate website at https://www.withuspharm.com/mastart/mastart.php, which serves as a platform for company information and updates. The company operates in the pharmaceutical industry, contributing to the production and supply of essential medications in South Korea. Withus Pharmaceutical's business model integrates both direct product sales and contract manufacturing services, supporting its role in the broader healthcare ecosystem. The company's operations are centered around the development and delivery of prescription drugs, with a focus on key therapeutic areas such as cardiovascular health, musculoskeletal conditions, gastrointestinal treatments, and infectious disease management. The firm's activities are conducted under the regulatory framework of South Korea's pharmaceutical industry, adhering to local standards for drug manufacturing and distribution. Withus Pharmaceutical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Withus Pharmaceutical Co stock

Interest Coverage Ratio of Withus Pharmaceutical Co is 11.75 in 2024.

Interest Coverage Ratio of Withus Pharmaceutical Co changed from 4.80 to 11.75, representing a 144.78% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio Withus Pharmaceutical Co since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's Withus Pharmaceutical Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Withus Pharmaceutical Co

All Key Metrics — Withus Pharmaceutical Co